Leukocyte disorders (white blood cell disorders) – pipeline
Upcoming SlideShare
Loading in...5
×
 

Leukocyte disorders (white blood cell disorders) – pipeline

on

  • 482 views

2012 Aarkstore.com | Leukocyte Disorders (White Blood Cell Disorders) – Pipeline Review, H2 2012

2012 Aarkstore.com | Leukocyte Disorders (White Blood Cell Disorders) – Pipeline Review, H2 2012

Statistics

Views

Total Views
482
Views on SlideShare
482
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Leukocyte disorders (white blood cell disorders) – pipeline Leukocyte disorders (white blood cell disorders) – pipeline Document Transcript

  • Leukocyte Disorders (White Blood Cell Disorders) –Pipeline Review, H2 2012Aarkstore.com announces, The Latest market research report is available inits vast collection:Leukocyte Disorders (White Blood Cell Disorders)– Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Leukocyte Disorders (White Blood Cell Disorders) - PipelineReview, H2 2012, provides an overview of the Leukocyte Disorders (White BloodCell Disorders) therapeutic pipeline. This report provides information on thetherapeutic development for Leukocyte Disorders (White Blood Cell Disorders),complete with latest updates, and special features on late-stage and discontinuedprojects. It also reviews key players involved in the therapeutic development forLeukocyte Disorders (White Blood Cell Disorders). Leukocyte Disorders (WhiteBlood Cell Disorders) - Pipeline Review, H2 2012 is built using data and informationsourced from Global Markets Direct’s proprietary databases, Company/Universitywebsites, SEC filings, investor presentations and featured press releases fromcompany/university sites and industry-specific third party sources, put together byGlobal Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Leukocyte Disorders (WhiteBlood Cell Disorders).- A review of the Leukocyte Disorders (White Blood Cell Disorders) products underdevelopment by companies and universities/research institutes based on
  • Leukocyte Disorders (White Blood Cell Disorders) –Pipeline Review, H2 2012information derived from company and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Table of contents:List of Tables 4List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Leukocyte Disorders (White Blood Cell Disorders) Overview 7Therapeutics Development 8An Overview of Pipeline Products for Leukocyte Disorders (White Blood CellDisorders) 8Leukocyte Disorders (White Blood Cell Disorders) Therapeutics under Developmentby Companies 10Leukocyte Disorders (White Blood Cell Disorders) Therapeutics under Investigationby Universities/Institutes 13Late Stage Products 16Comparative Analysis 16Mid Clinical Stage Products 17Comparative Analysis 17Early Clinical Stage Products 18Comparative Analysis 18Discovery and Pre-Clinical Stage Products 19Comparative Analysis 19Leukocyte Disorders (White Blood Cell Disorders) Therapeutics – Products underDevelopment by Companies 20Leukocyte Disorders (White Blood Cell Disorders) Therapeutics – Products underInvestigation by Universities/Institutes 22Companies Involved in Leukocyte Disorders (White Blood Cell Disorders)Therapeutics Development 24Kyowa Hakko Kirin Co., Ltd. 24GlaxoSmithKline plc 25Gamida Cell Ltd. 26Mochida Pharmaceutical Co., Ltd. 27
  • Leukocyte Disorders (White Blood Cell Disorders) –Pipeline Review, H2 2012STADA Arzneimittel AG 28Taiho Pharmaceutical Co., Ltd. 29Ligand Pharmaceuticals Incorporated 30Lupin Limited 31NexMed, Inc. 32Telik, Inc. 33Zenotech Laboratories Limited 34ProMetic Life Sciences Inc. 35Lipoxen PLC 36Green Cross Corporation 37Bolder Biotechnology, Inc. 38Welichem Biotech Inc. 39PharmaEssentia Corporation 40ImmuneRegen BioSciences, Inc. 41Pfenex Inc. 42Leukocyte Disorders (White Blood Cell Disorders) – Therapeutics Assessment 43Assessment by Monotherapy Products 43Assessment by Combination Products 44Assessment by Route of Administration 45Assessment by Molecule Type 47Drug Profiles 50Homspera - Drug Profile 50List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1
  • Leukocyte Disorders (White Blood Cell Disorders) –Pipeline Review, H2 2012Pulmonary Hypertension – Pipeline Review, H2 2012Leukocyte Disorders (White Blood Cell Disorders) – Pipeline Review, H2 2012Brain Metastasis – Pipeline Review, H2 2012Swine Influenza – Pipeline Review, H2 2012Adenocarcinoma – Pipeline Review, H2 2012Fungal Infections – Pipeline Review, H2 2012Mycobacterium Infections – Pipeline Review, H2 2012Brain Cancer – Pipeline Review, H2 2012Metastatic Colorectal Cancer – Pipeline Review, H2 2012Orthomyxoviridae Infections – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1
  • Leukocyte Disorders (White Blood Cell Disorders) –Pipeline Review, H2 2012For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com